The rising popularity in GLP-1 agonists for diabetes has generated a question about delivery routes : transdermal systems versus tablets . Usually , GLP-1 treatments were solely available in oral form, but the introduction of skin applications offers a different way. Skin applications might benefit individuals experiencing difficulty swallowing … Read More